Idoxifene is equipotent to tamoxifen in inhibiting mammary carcinogenesis but forms lower levels of hepatic DNA adducts

File(s)

Idoxifene is equipotent to tamoxifen in inhibiting mammary carcinogenesis but forms lower levels of hepatic DNA adducts.pdf (935.27 KB)

Published version

Show more

Author(s)

Pace, P

Jarman, M

Phillips, D

Hewer, A

Bliss, J

more

Type

Journal Article

Date Issued

1997-09-01

URI

http://hdl.handle.net/10044/1/53527

DOI

https://dx.doi.org/10.1038/bjc.1997.449

ISSN

0007-0920

Publisher

Churchill Livingsone

Start Page

700

End Page

704

Journal / Book Title

British Journal of Cancer

Volume

76

Issue

6

Copyright Statement

© 1997 Cancer
Research
Campaign

Identifier

http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1997XW48300003&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202

Subjects

Science & Technology

Life Sciences & Biomedicine

Oncology

ONCOLOGY

antioestrogen

N-methylnitrosourea-induced mammary tumour

DNA adducts

BREAST-CANCER

RAT HEPATOCYTES

PREVENTION

IDENTIFICATION

ANTIESTROGEN

ANALOGS

BINDING

TRIAL

Animals

DNA Adducts

Female

Liver

Mammary Neoplasms, Experimental

Methylnitrosourea

Rats

Survival Analysis

Tamoxifen

Time Factors

1112 Oncology And Carcinogenesis

Oncology & Carcinogenesis

Publication Status

Published